Wikidata

(Q28257174)

English

Phase III randomized multicenter study of a humanized anti-CD33 monoclonal antibody, lintuzumab, in combination with chemotherapy, versus chemotherapy alone in patients with refractory or first-relapsed acute myeloid leukemia

scientific article

In more languages

Statements

title
Phase III randomized multicenter study of a humanized anti-CD33 monoclonal antibody, lintuzumab, in combination with chemotherapy, versus chemotherapy alone in patients with refractory or first-relapsed acute myeloid leukemia (English)
0 references
author name string
Eric J Feldman
series ordinal
1
0 references
Joseph Brandwein
series ordinal
2
0 references
Richard Stone
series ordinal
3
0 references
Matt Kalaycio
series ordinal
4
0 references
Joseph Moore
series ordinal
5
0 references
Julie O'Connor
series ordinal
6
0 references
Nancy Wedel
series ordinal
7
0 references
Gail J Roboz
series ordinal
8
0 references
Carole Miller
series ordinal
9
0 references
Raj Chopra
series ordinal
10
0 references
Joseph C Jurcic
series ordinal
11
0 references
Randy Brown
series ordinal
12
0 references
W Christopher Ehmann
series ordinal
13
0 references
Philip Schulman
series ordinal
14
0 references
Stanley R Frankel
series ordinal
15
0 references
Daniel De Angelo
series ordinal
16
0 references
David Scheinberg
series ordinal
17
0 references
publication date
20 June 2005
0 references
volume
23
0 references
issue
18
0 references
page(s)
4110-6
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q28257174&oldid=1647962681"